跳转到主要内容
搜索

Certara Announces New Head of Clinical Pharmacology & Translational Medical Group

RADNOR, PA – 2024 年 10 月 30 日 – Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced the appointment of Dr. Tong Zhu, FCP‬, to lead its Clinical Pharmacology and Translational Medicine Group. Dr. Zhu will continue the group’s evolution of their mission to provide optimal clinical pharmacology strategy and quantitative, data-driven approaches to enhance decision-making throughout the drug development lifecycle.

“I am excited to welcome Tong to Certara as the head of our world-renowned Clinical Pharmacology and Translational Medicine Group,” said Fran Brown, PhD, Senior Vice President, Certara Drug Development Solutions. “Her long history in the pharmaceutical industry and expertise in early development, translational medicine, and clinical pharmacology make her the ideal choice to lead this group and continue our commitment to provide scientific rigor and customized development strategy for our industry partners.”

With nearly 25 years of experience specializing in translational medicine, early development, and clinical pharmacology, Dr. Zhu brings a wealth of knowledge in pharmaceutical research and development. Most recently she was responsible for leading Astellas’ Primary Focus strategy in Mitochondria Biology by working globally to help identify and develop innovative drugs targeting mitochondrial biology. 在 Astellas 近 14 年的职业生涯中,她曾在临床药理学与探索性开发部门担任过多个领导职务。加入 Astellas 之前,Dr. Zhu 在雅培全球药物研发部门(现为 AbbVie)的临床药理学和药物代谢动力学团队中担任了重要职位。

“Throughout my pharmaceutical career, I have known Certara as a trusted partner, providing software, solutions, and scientific leadership in drug development,” said Zhu. “I am excited to join Certara as the leader of the Clinical Pharmacology and Translational Medicine team and look forward to contributing to the mission of transforming drug development to accelerate the delivery of medicines that protect and enhance patient lives.”

关于Certara

Certara 致力于通过生物模拟软件、技术和服务加速药物研发,改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 66 个国家的监管机构。Learn more at www.certara.com.

Certara 联系人:
Sheila Rocchio
{1}

媒体联系人:
Alyssa Horowitz
{1}

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software